Latest Breaking News On - Molecular diagnostics business area - Page 6 : comparemela.com

QIAGEN Launches CE-marked Version of QuantiFERON SARS-CoV-2 to Assess T-cell Response to COVID-19

02.12.2021 - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today the CE marking of its QuantiFERON SARS-CoV-2 assay that measures T-cell responses to SARS-CoV-2 and aids in the assessment of immunity in individuals who have received COVID-19 . Seite 1

Jean pascal violaSenior vice presidentMolecular diagnostics business area

QIAGEN N V : QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2

Easy-to-use cartridge receives CE-marking in Europe and will launch soon Syndromic test differentiates between influenza A and B, RSV and SARS-CoV-2, a critical test for upcoming flu seasons

United statesJohn gilardiRobert reitzeJean pascal violaThomas theuringerPhoebe lohAmys foxMontefiore health systemDrug administrationExchange commissionMontefiore medical centerDepartment of pathologyLife sciencesClinical researchCorporate business developmentUs securities exchange

QIAGEN N V : QIAGEN Receives U S Department of Defense Contract to Further Expand Production Capacity for NeuMoDx

QIAGEN N V : QIAGEN Receives U S Department of Defense Contract to Further Expand Production Capacity for NeuMoDx
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Ann arborUnited statesJohn gilardiRobert reitzeJean pascal violaThomas theuringerPhoebe lohUs department of defenseExchange commissionDepartment of healthHuman servicesLife sciencesCorporate business developmentUs securities exchangeFrankfurt prime standardOriginal equipment makers

QIAGEN N V : QIAGEN Forms Strategic Alliance With Sysmex Corporation for Global Cancer Companion Diagnostics Development and Commercialization Using NGS and Plasma-Safe-SeqS Technology

QIAGEN N V : QIAGEN Forms Strategic Alliance With Sysmex Corporation for Global Cancer Companion Diagnostics Development and Commercialization Using NGS and Plasma-Safe-SeqS Technology
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesJohn gilardiRobert reitzeAsia pacificJean pascal violaThomas theuringerPhoebe lohHiroshi kandaExchange commissionJapan sysmex corporation tokyo stock exchangeHead of corporate business development at sysmexSysmex corporationTokyo stock exchangeCorporate business developmentUs securities exchangeFrankfurt prime standard

QIAGEN launches artus Prep&Amp as CE-marked SARS-CoV-2 test offering up to threefold increase in daily lab testing capacity

QIAGEN launches artus Prep&Amp as CE-marked SARS-CoV-2 test offering up to threefold increase in daily lab testing capacity
selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.

Jean pascal violaEuropean unionCorporate business developmentIndustry newsPrep ampEmergency use authorizationUniversal transport mediaSenior vice presidentMolecular diagnostics business areaஜீன் பாஸ்கல் வயலஐரோப்பிய தொழிற்சங்கம்பெருநிறுவன வணிக வளர்ச்சிதொழில் செய்திஅவசரம் பயன்பாடு அங்கீகாரம்உலகளாவிய போக்குவரத்து மீடியாமூத்தவர் துணை ப்ரெஸிடெஂட்